Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. Y T Kruszynska , J G Yu , J M Olefsky and B E Sobel Department of Endocrinology and Metabolism, University of California San Diego, Veterans Ad...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2000-04, Vol.49 (4), p.633-639
Hauptverfasser:	Kruszynska, Y T, Yu, J G, Olefsky, J M, Sobel, B E
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Arteriosclerosis - etiology Arteriosclerosis - prevention & control Atherosclerosis Blood Glucose - metabolism Chromans - therapeutic use Complications and side effects Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Female Fibrinolysis - drug effects Glucose Clamp Technique Health aspects Humans Hyperinsulinism - blood Hypoglycemic Agents - therapeutic use Insulin - blood Insulin Resistance Male Middle Aged Obesity Obesity - blood Obesity - complications Plasminogen Activator Inhibitor 1 - blood Thiazoles - therapeutic use Thiazolidinediones Tissue Plasminogen Activator - blood Troglitazone Type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!